Wikidata

(Q61936892)

English

Clinical Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Ponesimod in Patients With Relapsing-remitting Multiple Sclerosis

clinical trial

In more languages

Statements

title
Multicenter, Randomized, Double-blind, Parallel-group Extension to Study AC-058B201 to Investigate the Long-term Safety, Tolerability, and Efficacy of Three Doses of Ponesimod, an Oral S1P1 Receptor Agonist, in Patients With Relapsing-remitting Multiple Sclerosis (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
country
Austria
0 references
Bulgaria
0 references
Canada
0 references
Finland
0 references
France
0 references
Germany
0 references
Hungary
0 references
Israel
0 references
Italy
0 references
Netherlands
0 references
Poland
0 references
Romania
0 references
Serbia
0 references
Spain
0 references
Sweden
0 references
Switzerland
0 references
Ukraine
0 references
United Kingdom
0 references
start time
12 May 2010
0 references
end time
15 December 2021
0 references
number of participants
353
0 references
minimum age
18 year
0 references
maximum age
55 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61936892&oldid=2175869403"